OTIF Ventures
Venture capital
RollingLast verified 10 Nov 2026
UK venture capital firm investing from seed stage onwards into university deep-science spinouts across life sciences, deep tech, and physical sciences.
2 deals in the last 24 months, latest 3 Jun 2026. From its website and its deals in the news.
Key facts
- Stages
- Seed, Series C+
- Sectors
- Biotech & pharma, Medtech, Quantum, AI & machine learning, Hardware & IoT, Materials & chemistry
- Eligible countries
- Not stated
- Provider based in
- United Kingdom
- Timing
- Rolling applications
- Focus
- university deep-science spinouts; life sciences; deep tech; physical sciences
- How to apply
- Apply route unknown
- Source
- https://otif.vc/
Recent deals
| Company | Round | Sectors | Amount | Role | Announced |
|---|---|---|---|---|---|
| OQC | Series C+ | Quantum, Hardware & IoT | €311.7M | – | 3 Jun 2026 |
| Oxford Quantum Circuits | Series C+ | Quantum, Hardware & IoT | €311.7M | – | 3 Jun 2026 |
Evidence
Short excerpts from the sources, in their original language, that back the facts above.
- Kind
OTIF provides sophisticated investors with access to high-potential university spinouts. We focus on long-term capital growth and portfolio diversification
https://otif.vc/ - Sectors
Life Sciences Advancing breakthroughs in therapeutics, medical devices and life science tools
https://otif.vc/ - Stages
Founded in 2015, we invest in companies from Seed and follow-on through to Exit.
https://otif.vc/
Status history
- 6 Nov 2026: Rolling (first extraction)
Is something out of date?
Suggest an editTakes 10 seconds
Something else wrong? Report an error.
Work at OTIF Ventures? Claim this profile to confirm what you invest in.